Literature DB >> 29895982

Anti-TNF Exposure in Utero, What About My Twins?

Sunanda Kane1, Brenda Becker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29895982      PMCID: PMC6768598          DOI: 10.1038/s41395-018-0165-x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  2 in total

1.  Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

Authors:  M Chaparro; A Verreth; T Lobaton; E Gravito-Soares; M Julsgaard; E Savarino; F Magro; Avni I Biron; P Lopez-Serrano; M J Casanova; M Gompertz; S Vitor; M Arroyo; D Pugliese; Y Zabana; R Vicente; M Aguas; Bar-Gil A Shitrit; A Gutierrez; G A Doherty; L Fernandez-Salazar; Martínez J Cadilla; J M Huguet; A OʼToole; E Stasi; Manceñido N Marcos; A Villoria; K Karmiris; J F Rahier; C Rodriguez; Diz-Lois M Palomares; G Fiorino; J M Benitez; M Principi; T Naftali; C Taxonera; G Mantzaris; L Sebkova; B Iade; D Lissner; Ferrer I Bradley; Lopez-San A Roman; I Marin-Jimenez; O Merino; M Sierra; M Van Domselaar; F Caprioli; I Guerra; P Peixe; M Piqueras; I Rodriguez-Lago; Y Ber; K van Hoeve; P Torres; M Gravito-Soares; D Rudbeck-Resdal; O Bartolo; A Peixoto; G Martin; A Armuzzi; A Garre; M G Donday; Martín F J de Carpi; J P Gisbert
Journal:  Am J Gastroenterol       Date:  2018-02-20       Impact factor: 10.864

2.  Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-25       Impact factor: 8.661

  2 in total
  1 in total

1.  Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.

Authors:  María Chaparro; Javier P Gisbert
Journal:  Am J Gastroenterol       Date:  2018-10-24       Impact factor: 10.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.